This inventor holds 1 USPTO granted patent. Top assignee: Carlo Erba. Active years: 1977.
Company Filing History:
Years Active: 1977
Title: Giovanni Riasoli: Innovator in Platelet Anti-Aggregating Compounds
Introduction
Giovanni Riasoli is a notable inventor based in Vanese, Italy. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that address platelet aggregation disorders. His work has the potential to impact the treatment of various syndromes related to these disorders.
Latest Patents
Riasoli holds a patent for "Isoindoline derivatives having platelet anti-aggregating activity." This patent describes a composition and method for the prevention and treatment of syndromes caused by platelet-aggregation disorders. The active ingredient in this invention is a compound characterized by a specific formula, where R can be hydrogen or a C1-C4 alkyl group, and R1 can be hydrogen, a C1-C4 alkyl group, or another specified structure. This innovative approach aims to provide effective solutions for patients suffering from these conditions.
Career Highlights
Giovanni Riasoli is associated with Carlo Erba, a company known for its contributions to the pharmaceutical industry. His work at Carlo Erba has allowed him to focus on the development of new therapeutic agents that can improve patient outcomes. Riasoli's dedication to research and innovation has positioned him as a key figure in his field.
Collaborations
Riasoli collaborates with Pier Nicola Giraldi, a fellow researcher who shares his commitment to advancing medical science. Their partnership exemplifies the collaborative spirit that drives innovation in the pharmaceutical sector.
Conclusion
Giovanni Riasoli's contributions to the field of platelet anti-aggregating compounds highlight his role as an important inventor in medicinal chemistry. His patent and ongoing work at Carlo Erba demonstrate his commitment to improving healthcare through innovative solutions.